Spexis AG Logo

Spexis AG

SPEX | SW

Overview

Corporate Details

ISIN(s):
CH0106213793
LEI:
391200S8HJE1I96FIG04
Country:
Switzerland
Address:
Hegenheimermattweg 125, 4123 Allschwil
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Headquartered in Switzerland and Boston, two global biotech-hubs, our ambition is to develop Spexis into a leading biopharmaceutical company with a strategic focus on rare diseases, oncology and antimicrobial resistance. With a strong scientific core, our drug discovery and research efforts are led by our in house scientist via leveraging our discovery platforms in collaboration with top academic centers around the globe. We have two clinical programs focused on products for rare, chronic respiratory diseases. Spexis AG is a combination of the two legacy companies, Polyphor, a publicly listed Swiss biotech and EnBiotix, a privately held US biotech. In December 2021, two companies – Polyphor and EnBiotix – teamed up to join forces and formed Spexis.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Spexis AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-11-05 07:15
Delisting Announcement
Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently.
English 9.3 KB
2024-11-05 01:00
Delisting Announcement
Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently.
English 7.7 KB
2024-07-29 07:15
Legal Proceedings Report
Spexis granted definitive moratorium status until 25 November 2024, subject to …
English 8.6 KB
2024-07-29 02:00
Legal Proceedings Report
Spexis granted definitive moratorium status until 25 November 2024, subject to …
English 6.9 KB
2024-07-22 07:15
Legal Proceedings Report
Spexis expects that audit of its 2023 financials will not be completed by 31 Ju…
English 10.8 KB
2024-07-22 02:00
Legal Proceedings Report
Spexis expects that audit of its 2023 financials will not be completed by 31 Ju…
English 9.1 KB
2024-07-08 07:15
Legal Proceedings Report
Spexis AG: PARI Pharma GmbH announces termination of ColiFin license to EnBioti…
English 10.0 KB
2024-07-08 02:00
Legal Proceedings Report
Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiot…
English 8.4 KB
2024-06-04 20:00
Delisting Announcement
Spexis launches appeal against SIX Exchange Regulation decision to suspend trad…
English 8.0 KB
2024-06-04 02:00
Delisting Announcement
Spexis launches appeal against SIX Exchange Regulation decision to suspend trad…
English 6.4 KB
2024-05-31 22:00
Report Publication Announcement
Spexis receives second extension for the publication of its 2023 annual report …
English 19.4 KB
2024-05-31 02:00
Report Publication Announcement
Spexis receives second extension for the publication of its 2023 annual report …
English 16.6 KB
2024-04-30 20:30
Report Publication Announcement
Spexis receives approval of an extension of the deadline for the publication of…
English 9.8 KB
2024-04-30 02:00
Report Publication Announcement
Spexis receives approval of an extension of the deadline for the publication of…
English 8.2 KB
2024-04-17 07:15
Regulatory News Service
Spexis announces extension of moratorium, receipt of an additional payment rela…
English 13.8 KB

Automate Your Workflow. Get a real-time feed of all Spexis AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Spexis AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-06-21 N/A Executive member Other None N/A

Peer Companies

Company Country Ticker View
Curevac Logo Curevac Germany CVAC
Cyclezyme AB Logo Cyclezyme AB Sweden CYCLE
Cyxone AB Logo Cyxone AB Sweden CYXO
DBV Technologies Logo DBV Technologies France DBV
DEINOVE Logo DEINOVE France ALDEI
Deutsche Biotech Innovativ AG Logo Deutsche Biotech Innovativ AG Germany DBI
Devyser Diagnostics Logo Devyser Diagnostics Sweden DVYSR
Diamyd Medical AB (publ) Logo Diamyd Medical AB (publ) Sweden DMYD
Diasorin Logo Diasorin Italy DIA
DNA Group (T.R.) Ltd. Israel DNA